Recombinant Human IL-11
Interleukin-11 (IL-11) is a pleiotropic cytokine in the IL-6 family, which also includes LIF, CNTF, Oncostatin M, Cardiotrophin-1, IL-27 and IL-31 [1-3]. In humans, IL-11 was also independently discovered as an adipogenesis inhibitory factor (AGIF) [3]. The human IL-11 cDNA encodes a 199 amino acid (aa) precursor, which generates a 178 aa, 19 kDa mature unglycosylated protein. Mature human IL-11 shares 88%, 88%, and 96% aa sequence identity with mouse, rat and canine IL-11, respectively. IL-11 is secreted by osteoblasts, synoviocytes, fibroblasts, chondrocytes, intestinal myofibroblasts, and trophoblasts, among other cell types [1]. It is found in the plasma mainly during inflammation, such as that associated with viral infection, cancer, or inflammatory arthritis, and is considered to be primarily anti-inflammatory [1]. It stimulates hematopoiesis and thrombopoiesis, regulates macrophage differentiation, and confers mucosal protection in the intestine [1]. It has also been found to enhance T cell polarization toward Th2, promote B cell IgG production, increase osteoclast bone absorption, protect endothelial cells from oxidative stress, and regulate epithelial proliferation and apoptosis [1]. IL-11 synergizes with several other cytokines to produce these effects, and its effects overlap with those of IL-6 [1]. IL-11 receptor activation requires formation of a complex of two IL-11 molecules with two molecules of the ligand-binding IL-11 R alpha subunit and two molecules of the ubiquitously expressed cell signaling beta subunit, gp130 [4]. A soluble form of IL-11 R alpha can bind IL-11 and either form a signaling complex with gp130 on the cell surface, or inhibit cell surface IL-11 R alpha /gp130 signaling [5-7].
Reference
[1]. Putoczki, T. and M. Ernst (2010) J. Leukoc. Biol. 88:1109.
[2]. Paul, S.R. et al. (1990) Proc. Natl. Acad. Sci. USA 87:7512.
[3]. Kawashima, I. et al. (1991) FEBS Lett. 283:199.
[4]. Barton, V.A. et al. (2000) J. Biol. Chem. 275:36197.
[5]. Curtis, D.J. et al. (1997) Blood 90:4403.
[6]. Baumann, H. et al. (1996) J. Immunol. 157:284.
[7]. Karow, J. et al. (1996) Biochem. J. 318:489.
Accession # |
P20809.1 |
Alternate Names |
Human IL11; IL11; IL-11; Oprelvekin; interleukin 11; interleukin-11; Adipogenesis inhibitory factor |
Source |
Human embryonic kidney cell, HEK293-derived human IL-11 protein |
Protein sequence |
Pro22-Leu199 |
M.Wt |
19.1 kDa |
Appearance |
Solution protein. |
Stability & Storage |
Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 12 months from date of receipt, -20 to -70 °C as supplied. |
Concentration |
0. 2 mg/mL |
Formulation |
Dissolved in sterile PBS buffer. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers. |
Biological Activity |
Measured in a cell proliferation assay using T11 mouse plasmacytoma cells. The EC50 for this effect is 0.02-0.10 ng/mL |
Shipping Condition |
Shipping with dry ice. |
Handling |
Centrifuge the vial prior to opening. |
Usage |
For Research Use Only! Not to be used in humans. |
Quality Control & DataSheet
- View current batch:
-
Purity > 95%, determined by SDS-PAGE.
- Datasheet
Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.